Critically, NRF2 has been shown to play an important role in mitigating the onset and progression of several neurodegenerative diseases, including Parkinson’s disease (PD), Alzheimer’s disease (AD), Huntington’s disease (HD), and Multiple sclerosis (MS) (Cuadrado, 2022). Here, NFE2L2 is linked to multiple sclerosis.